Prominent Pharmacologist Dies

Bill Bowman, champion of modern anesthetics and the founding professor of pharmacology at Strathclyde University in Glasgow, has passed away at age 83.

Written byTracy Vence
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

BOWMAN FAMILYBill Bowman, whose work led to improvements in general anaesthetics, died July 18. He was 83. Bowman founded the U.K.’s Strathclyde University pharmacology department in 1966. He continued his research—working to understand muscle-relaxing drugs and developing safer alternatives—there in Glasgow until he was named vice principal of Strathclyde, and later retired, after 30 years with the university. Among his achievements were the development of both vecuronium and rocuronium, which today are two of the most widely used muscle relaxants in anesthetic practice. Throughout his career, Bowman was a visiting professor at several institutions across Australia, Canada, Europe, and the U.S., and served on government drug safety committees and more than a dozen editorial boards.

“We have lost an inspirational teacher, a brilliant lecturer, a walking encyclopedia of pharmacology and a mentor to numerous pharmacologists around the globe,” wrote Bowman’s colleagues Jim Parratt, Brian Furman, and Peter West in Glasgow's The Herald.

According to The Guardian, Bowman’s true calling was academic research. When he took on administrative roles at the university, he reportedly said: “Someone has to take a turn at these chores, but nothing beats contact with students and getting your hands dirty at the laboratory bench.”

Bowman is survived by two children and four grandchildren.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies